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2ABSTRACT
Objective: Investigate the accuracy of stent measurements using coronary x-
ray angiograms with a computer based stent enhancement algorithm applied
(StentBoost, SB). To derive recommendations for best practice when using
such systems.
Background: Computer enhancement algorithms allow better visualisation of
intra-coronary stents to assist in ensuring adequate stent deployment. Factors
that affect the accuracy of measurements taken on such systems are yet to
be fully understood.
Methods: We analysed stent deployment of 43 stents in 33 patients
measuring minimum stent diameter and cross sectional area (CSA) using
intravascular ultrasound (IVUS), SB enhanced x-ray images, and quantitative
coronary angiography (QCA). We investigated if the use of two projections
and method of calibration influenced correlation between IVUS and SB
measurements.
Results: Using two views and performing calibration via the guide catheter
improved agreement between SB and IVUS measurements. E.g. minimum
stent diameter assessed with SB using one view and balloon markers for
calibration produced a correlation coefficient, r, of 0.21, whereas using two
views and the guide catheter for calibration increased improved agreement to
r=0.62 . Relative measures of stent deployment, such as the ratio of minimum
to maximum CSA, produced good correlation between IVUS and SB (r=0.74).
3Conclusions: When using the SB system, two projection angles should be
used to image the stent. For absolute measurements, the guide catheter
should be used for calibration purposes. Relative measures of stent size,
which are probably sufficient for assessment of deployment, also give good
agreement with similar measures on IVUS, and require no calibration.
4INTRODUCTION
Under deployed intra coronary stents are associated with poorer patient
outcomes. One of the limitations in visualising stents on conventional
coronary angiography is related to the low x-ray subject contrast due to the
thinner struts of modern stents, despite the use of highly radio-opaque
materials in stent construction. Motion of the stent within an imaging
sequence further reduces stent visibility. In larger patients increased scatter to
primary ratio and the higher x-ray tube voltages typically used when imaging
these patients, reduce radiographic contrast of the stent compared to thinner
patients, making the visualisation of stents particularly challenging in these
patients. Intravascular ultrasound (IVUS) is superior to conventional
angiography for the detection of stent under-deployment and strut
malapposition, and its routine use to optimise stent deployment may reduce
the rate of subsequent need for target lesion/vessel revascularisation [1-3].
However, routine IVUS adds cost, time and increases the risk procedural
complications, with little or no effect on rates of subsequent death or
myocardial infarction (MI) [4]. IVUS is therefore unlikely to be cost-effective
[5]. Quicker, cost effective and less invasive means of improving recognition
of stent under-deployment is therefore desirable.
Recently, computer enhancement algorithms for enhancing stent visibility in x-
ray angiograms have been described [6-8]. This study used a commercial
stent enhancement algorithm called StentBoost (Philips Healthcare, The
Netherlands). The StentBoost (SB) system combines information from a
sequence of image frames to form a composite image, with the intention of
5improving the visibility of a stent. The system has been described as being
used to assist with the deployment of stents [9-12], in assessing if a stent is
correctly deployed, or for assessing other complications such as stent fracture
[13-15]. To utilise the SB system, a digital cine run is acquired immediately
after stent deployment with the balloon deflated before it was withdrawn from
the vessel (figure 1a). The SB algorithm fixes the stent in space throughout
the cardiac cycle by aligning and registering the radio opaque markers of the
deployment balloon at the same location throughout the acquisition sequence.
The sequence is then temporally averaged to obtain a single composite image
(figure 1b). In this study, the software was used retrospectively for quantitative
assessment of the stent diameter and length.
Two recent studies have compared quantitative measurements taken with SB
to measurements taken using IVUS [16,17], although both are single centre
small studies, the latter having a particularly small number of stents studied (n
= 19). Both studies found good correlation between minimum stent diameter
measured via SB and IVUS (r = 0.79 [16] and 0.80 [17]), although there are
important differences in the methodologies used. It is standard angiographic
practice to image a vessel (and deployed stent) from two or more projection
angles to ensure adequate depiction of the vessel shape given the projection
nature of the angiographic imaging technique. Mishell at al [16] only employed
assessment of stents via a single angiographic sequence, i.e. the stent was
examined at one projection angle only, whereas Cordova et al [17] utilised two
views although how data were combined from the two views is not explicitly
6stated. The question as to whether two views of a stent are required for
adequate assessment of stent deployment remains unanswered.
Both Mishell et al and Cordova et al used SB measurements of minimal stent
diameter were compared to minimal stent diameter measured on IVUS. This
has two disadvantages. Firstly IVUS is a cross sectional imaging device,
allowing cross sectional area (CSA) to be assessed, and it is minimum CSA,
not minimum diameter, that is key to flow limitation. Secondly, assessment of
minimum stent diameter requires an absolute measurement of an object
within the image. One of the biggest limitations to any absolute measurement
of an object size in any projection x-ray image, is the requirement to calibrate
measurements via an object of known size located in the same plane as the
object to be measured. In cardiac images calibration is typically performed
using the guide catheter. This may require a larger field of view than
necessary just to visualise the stent in a SB sequence resulting in a larger
radiation dose to the patient, lower image quality due to increased scatter,
adds an additional stage to the image analysis, and may be cumbersome to
achieve in clinical practice. An alternative object to calibrate measurements to
with SB is the markers for the balloon inflation device, which have the
advantage that they are always within the field of view, but may be subjected
to a degree of foreshortening, making absolute measurements less accurate.
Using a ratio of measurements from the same image sequence would remove
the requirement for calibration, and if a relative measure can be used to
assess stent deployment instead of an absolute measure of stent dimension,
7quantitative measurements with SB would be simpler to achieve in clinical
practice, and require fewer steps in the calculation process.
In this prospective study, we set out to investigate:
a) whether or not the accuracy of stent assessment improves when the
stent is imaged from two near-orthogonal projection angles rather than
using a single view
b) if the use of the balloon markers can be used for size calibration
without loss of accuracy compared to when using the guide catheter
c) if a relative measure of stent deformity can be used to assess stent
deployment avoiding the need for absolute calibrated measurements,
and
d) if stent measurements obtained with SB provide additional information
to that available with Quantitative Coronary Angiography (QCA) in
assessing stent deployment.
The overall aim of the study was to provide indicators of best practice to users
and potential users of the SB system.
8MATERIALS AND METHODS
This study was approved by the local research ethics committee and all data
were independently assessed. Only patients who had previous interventions
to the same arterial segment of interest and patients in whom two orthogonal
angiographic views of the stented segment could not be performed were
excluded. The computer enhancement algorithm used in this study was
available commercially - “StentBoost®” Version 1.0 (Philips Medical Systems
Nederland BV, Best, The Netherlands).
Data Acquisition
In 33 patients undergoing PCI and stent procedures at our centre, we studied
43 stent deployments. Immediately following stent deployment, SB images
were obtained in two projections as orthogonal to each other as practicable,
with minimal foreshortening of the stented segment chosen by the
interventionalist. The first of the two views was acquired using the projection
found in the diagnostic angiograms performed earlier in the procedure to
provide the clearest view of the stenosis. All data were acquired following a
bolus of intracoronary nitroglycerin. The heart was not isocentered prior to the
image acquisition.
A specific digital cine acquisition mode was selected on our x-ray system
(Philips Allura Xper FD10, Philips Medical Systems Nederland B.V., Best, The
Netherlands) in order to acquire a SB stent sequence. This acquisition was
performed without any contrast injection and with arrested respiration. The
9image data were automatically transferred to a dedicated computer
workstation within the catheter lab for processing by the SB system.
Although the enhanced (stent) images from the SB system can be analysed
rapidly for use ‘on-line’ within the catheterisation laboratory, for the purposes
of this study the data were analysed ‘off-line’ some time following the
completion of the cases.
Immediately following the SB data acquisition, and prior to any further post-
dilatation, IVUS was performed using the Galaxy II system (Boston Scientific,
Maple Grove, MN, USA) and IVUS Atlantis SR Pro catheters (Boston
Scientific, Maple Grove, MN, USA), producing 2D cross-sectional images at a
rate of 30 frames per second. An automated pullback device was used for all
IVUS data acquisition running at a speed of 0.5 mm per second. The IVUS
images were made available to the operator to further optimise stent
deployment if required, although as all quantitative analysis was performed
after the cases had been completed measurements from IVUS and SB were
not used to guide the procedure.
Data Analysis
All quantitative measurements for the purpose of this study were performed
‘off-line’ using the following procedure. Measurements from each modality
were made independently without reference to the other data. SB and IVUS
images were analysed by the same observers, but this analysis was
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performed some months apart to minimise bias due to familiarity with the
cases. QCA analysis was performed by different observers.
IVUS measurements of intra-luminal CSA and minimum and maximum
diameters were taken at the distal end of the stent and following every 60
frames (equivalent to 1 mm pullback) until the proximal end of the stent was
visualised. In-stent CSA was defined as the area bound by the visible stent
struts, measured by interactive planimetry. The distal and proximal ends of
the stent were defined as the first and last frames (respectively) in which at
least 75% of the circumference of the image had visible stent struts. In
addition we obtained measurements of CSA and minimum and maximum
diameters at reference points within the native vessel lumen and within 3 mm
of the ends of the stent of the native vessel when the anatomy permitted.
The SB images were analysed in much the same manner as the IVUS
images. Stent diameter was measured every 1 mm throughout the length of
the stent. Calibration of distance within the SB images was performed using
two objects- the balloon markers and the guide catheter end where possible.
Following an interactive manual tracing of the edges of the stent, the SB
software can calculate the diameter at any point along the length of the stent.
Measurements of stent diameter were taken in each view at proximal and
distal ends of the stent and at 1 mm intervals along the length of the stent. We
assumed that the final dimensions of the deployed stent length approximated
to the stated manufacturers’ specification - we therefore did not take into
account any ‘shortening’ of the stent which may have resulted at the time of
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deployment. Quantitative measurements using the distance between the
balloon markers as a reference was possible for all deployments in both
views, while quantitative measurement using catheter dimensions as
reference was only feasible when the guide catheter was clearly visible.
Quantitative Coronary Angiography analysis was performed using a
commercially available interactive semi-automated software of the
angiographic system (Philips Allura Xper-FD 10, Philips Medical Systems
Nederland B.V., Best, The Netherlands). Contrast filled guide catheter was
used for the calibration, and fully opacified segments of the related vessel
which provided optimal visualisation without foreshortening of the
stent/treated lesion was assessed. Minimum luminal diameter was recorded
within the vessel region where the stent was placed.
The following comparisons were made: minimum diameters (dmin) on IVUS to
SB and QCA, minimum cross sectional area (CSAmin) on IVUS to a
corresponding estimate on SB and QCA (PI x (dmin/2)2 ), and the ratio of the
minimum to maximum CSA on IVUS to the square of the ratio of minimum
and maximum stent diameters on SB.
For all SB and QCA measurements, measurements were made using two
views. The first view was the view chosen as the primary view used during the
intervention; the second was selected to be as close to orthogonal to the
primary view with minimal foreshortening of the segment. Results are
presented from the primary view alone, and for a combined measurement
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from the two views, which was calculated by taking the “worst case”
measurement (e.g. lowest dmin, or lowest ratio of minimum to maxiumum
diameter) from the two views.
Statistical Analysis
For each comparison the correlation co-efficient (r) between the reference
IVUS measurement and the corresponding SB or IVUS measurement was
calculated and Bland-Altman analysis was performed. All analysis was
performed using software written in MATLAB R2009b (Mathworks Inc, Natick
MA).
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RESULTS
The stents used in this study included; Tecnic (Sorin Biomedica, Via
Crescentino, Italy) 11, Driver (Medtronic, Minneapolis, MN, USA) 26, Cypher
(Cordis UK, Ascot, Berks, UK) 6. Stent lengths ranged from 12 mm to 33 mm
per deployment (mean 18 mm). The mean angle subtended between the two
projections used for the SB views was 59 (sd=24).
Correlation coefficients, r, and associated p values for all comparisons are
given in Table 1. In all cases, for SB and QCA comparisons, using two views
gave better correlations to IVUS measurements than using a single view. This
effect was smaller for QCA data. For example, comparing dmin measurements
using catheter calibration, r for SB correlation with IVUS was 0.46 and 0.62
using a single view and two views respectively. For the same comparison
QCA resulted in r values of 0.47 and 0.51 for one and two views respectively.
In all cases using catheter calibration improved the correlation of stentboost
measurements with IVUS over using the balloon markers. For example,
assessing minimum CSA with SB using two views, comparing to IVUS,
produced r=0.63 and r=0.9 for the balloon and catheter calibrations
respectively.
In all cases SB provided comparable or occasionally better agreement with
IVUS than QCA.
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The relative measurement of CSAmin/max provided good agreement between
SB and IVUS (r = 0.74 for two views). Selected Bland-Altman and scatter
diagrams are given in figures 2 – 4.
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DISCUSSION
There are many factors implicated in the development of restenosis, these
include clinical ones such as diabetes, smoking etc, procedural parameters
such as stent length, number of stents, deployment balloon size and pressure,
post-procedure minimum lumen diameter and cross-sectional area and
anatomical features like small vessels, long lesions, chronic total occlusions,
ostial lesions, vein grafts, calcified lesions etc. to name a few. Although many
studies have analysed the stent dimensions at the conclusion of the
procedure, they have suggested different absolute ‘cut-off’ values for post-
procedural CSA by IVUS and subsequent risk of restenosis (e.g. CSA 6.0 –
7.0 mm2) [18,19]. It is also known that there are discrepancies in measuring
luminal diameters using IVUS and QCA and that the magnitude of error varies
according to disease extent [20] and vessel size [21]. It has been supposed
that differences between QCA measurements and IVUS measurement were
due in part to the fact that in some cases the vessel was highly eccentric,
leading to large errors in the QCA measurement due to the fact that it was
obtained from a single projection. In such cases the use of two views over a
single view is likely to improve the assessment of the minimum diameter of
the vessel in the case of eccentric lesions. IVUS, which is a cross sectional
imaging modality, is capable of describing highly eccentric vessels. Our
results, which demonstrated improved measurement correlation with IVUS
when two views are obtained in QCA and SB support this proposition. There
will be inaccuracies in IVUS diameter measurements, however, when the
IVUS catheter is not parallel to the vessel wall.
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Absolute measurements (dmin and CSAmin) improved in accuracy with
reference to similar results taken on IVUS when the guide catheter was used
to calibrate the measurements compared to using the balloon markers for
callibration. Calibration with the balloon markers is likely to be affected by
foreshortening along the longitudinal axis of the vessel; measurements made
in the orthogonal direction (i.e. vessel or stent diameter) are unlikely to be
subjected to the same degree of foreshortening; when there is foreshortening
of the balloon markers, calibration using these points will be incorrect, and not
necessarily proportional to errors in the stent diameter; increasing the
foreshortening of a vessel will decrease its projected length, but may not alter
the projected width (diameter). Calibration via the guide catheter is not
subjected to this problem, although it is clearly important that the catheter is in
the same plane as the vessel for accurate calibration. If the source to object
distances for the catheter and vessel are not the same, there will be a scaling
error in any measurements taken. For example, this will occur in the RAO
projection in the distal left circumflex artery- in this case stent measurements
will be underestimated.
The use of a relative measurement, such as minimal luminal diameter with
respect to either the maximum luminal diameter within the stent or the
reference vessel, is a more convenient method of assessing stent deployment
in SB or QCA images as a calibration procedure is not required. A similar
relative measure has been proposed for IVUS as a predictor of restenosis
[21,22]. Our results indicate that a relative measure of the ratio of minimum to
maximum stent measurement demonstrates good correlation between SB and
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IVUS. This comparison was not performed with QCA, as it was difficult to
identify the exact proximal and distal ends of the stent in the QCA sequences
to ensure that the measurements were taken within the stent. We note that
later revisions of the SB software allow the enhanced stent to be super-
imposed upon the vessel allowing stent diameter to be assessed in the
context of the size of the surrounding vessel, in addition to the intra-stent
diameters.
Another advantage of using a relative measure for assessing stent
deployment is that it is not necessary to ensure the guide catheter is visible
within the imaged segment. This allows the x-ray beam collimators to be used
to more tightly delimit the image area around the stent. The smaller field of
view will result in lower doses of radiation to the patient and staff per SB run.
Moreover the smaller irradiated area of the patient will produce fewer
scattered x-ray photons, improving the image quality via a lower scatter to
primary ratio.
It is likely that the findings of this study are not limited to the SB product, but
would apply to any stent enhancement software that works in a similar
manner, i.e. combines information from a sequence of images taken in the
same projection. For all these systems more than one projection of the stent
should be imaged.
The operators in this study were instructed to obtain two views of a stent at
projection angles as close to orthogonal as practicable. Our results indicate
18
that the angles chosen in this study were somewhat less than orthogonal in
most cases, probably due in part to the need to find projections that do not
overlap the stent with other objects (diaphragm, surgical clips, etc.), have an
acceptable degree of foreshortening, and acceptable radiation dose to the
patient and staff. It is likely that the error in assessing stent diameter will
increase with more eccentric vessels and smaller angular differences between
projections. Nevertheless our results indicate that with simple instruction, and
suitable clinical experience, our operators could obtain better results from the
SB system by using two projections. Figure 5 demonstrates the value of using
two projections, showing an under-deployed stent imaged from the two angles
chosen by the operator in this study. The stent appears reasonably deployed
in one view (5a), yet there is clear under-deployment in the other view (5b).
There was an 85° angle between the two projections in this case.
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CONCLUSIONS
As new technological developments, such as SB, are integrated into clinical
routine, it is important that evidence is gathered to guide good practice when
using the new technology. To this end, our results indicate that when using
SB to assess stent deployment, two views as close to orthogonal as
practicable, of the stent should be acquired, and that a relative measure of
stent diameter (i.e. the ratio of the minimum to maximum diameter) correlate
well to measurements taken on IVUS. The radiation field should be collimated
tightly around the stent in order to minimise radiation dose and improve image
quality.
If absolute measurements of stent size are desired, SB can provide accurate
assessment of a deployed stent. In such cases, it is important to ensure that
the guide catheter is visible within the image for calibration purposes, and that
two orthogonal projections are taken of the stent.
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FIGURE LEGENDS
Figure 1: Image enhancement algorithm in practise; (a) positioning the balloon
markers just outside the stent, and (b) the enhanced image.
a)
b)
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Figure 2: Bland-Altman plots of minimum diameter measured on IVUS and
SB. a) balloon calibration, single view. b) balloon calibration, two views. c)
catheter calibration, single view. d) catheter calibration, two views.
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Figure 3: Bland-Altman plots of minimum CSA on IVUS and estimated from
SB. a) balloon calibration, single view. b) balloon calibration, two views. c)
catheter calibration, single view. d) catheter calibration, two views.
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Figure 4: Bland-Altman and scatter plots of CSA minimum to maximum ratio
measured on IVUS and estimated on SB. a) & c) single view, b) & d) two
views.
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Figure 5: StenBoost enhanced image from two projections a) 29° RAO 19°
Caudal, and b) 44° LAO, 28° Cranial.
